William L. Macias - Jan 5, 2022 Form 4 Insider Report for Immunovant, Inc. (IMVT)

Role
Chief Medical Officer
Signature
/s/ Eva Renee Barnett, attorney-in-fact for William L. Macias
Stock symbol
IMVT
Transactions as of
Jan 5, 2022
Transactions value $
-$222,012
Form type
4
Date filed
1/7/2022, 11:39 AM
Previous filing
Nov 9, 2021
Next filing
Apr 20, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction IMVT Common Stock Sale -$222K -26.8K -11.96% $8.28 197K Jan 5, 2022 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 On June 11, 2021, the holder was granted 93,371 restricted stock units ("RSUs"), as previously reported on a Form 4 filed on June 15, 2021. These RSUs vested in their entirety on December 31, 2021. Amounts reported herein represent shares sold by the holder solely to satisfy the holder's tax withholding obligation due in connection with the vesting and settlement of these RSUs.